Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Gemcitabine + Cisplatin in Advanced Pleural Mesothelioma
NCT01869023Phase 2Unknown
- Start
- Nov 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in malignant pleural mesothelioma (MPM). Status: unknown.
02
Drugs
gemcitabine
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01869023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01869023.